Brain changes associated with Alzheimer's disease can be detected by a new type of blood test — and a growing number of patients are asking their doctors about it. SUSAN DANCER: I wanted to know. And a few days later, got…
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. CervoMed Announces Publication of Two…
An analysis of the medical records of more than 2,000 deceased former NFL players estimates that a staggering 74.5% of them likely had chronic traumatic encephalopathy, a neurodegenerative brain disease tied to high-impact sports such as football. Boston University has been on…
SAN DIEGO — As demand increases for anti-amyloid therapy that can slow the progression of Alzheimer’s disease, it will be crucial for healthcare systems to find more efficient ways to review referrals for treatment, according to a presenter. For example, Sutter…
Researchers set out to estimate how prevalent CTE was across the full group, while accounting for the bias that comes from past studies relying on brain donors, who are more likely to have had symptoms. After reviewing the players’ histories…
New blood tests, such as plasma p-tau217, are transforming Alzheimer's care by helping identify disease pathology earlier and closer to home. Meanwhile, disease-modifying therapies like lecanemab and donanemab target brain amyloid and have demonstrated slower cognitive decline in clinical trials. Two…
by Koo Kyo Yun This article has been translated AI. Registration Number: Seoul, Ah01174 Registration Date: 2010.03.19 Date of issue: October 14, 2005 Editor: Im Ho-jun Title: Health Chosun Company Name: Health Chosun Co.Ltd Address: 30, Sejongdaero 21-gil, Jung-gu, Seoul Youth Protection Officer: Pyo…
Restricted Flow. The width (red bar) of a rat cortical capillary (left) shrinks in the vicinity of a pericyte (white arrowheads) after addition of Aβ (right). [Courtesy of Nortley et al., Science/AAAS.] The authors made similar observations in APPNL-G-F…
The presentations highlight advances in AviadoBio’s proprietary vMiX™ RNA interference (RNAi) gene silencing platform, including deep and durable tau protein lowering through six months in mice in the AVB-406 program and dose-dependent silencing of SNCA, the gene encoding alpha-synuclein, in…
BOSTON, Oct. 29, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to evaluate the eShunt System…
Alzheimer's research and treatment: lecanemab and donanemab, blood tests for diagnosis, trial results and what the latest studies find about the disease.
An article joins this feed when it matches these terms. Each one is also a search of its own.